{
    "title": "London-listed drugmaker Indivior shares crash after U.S. patent blow",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-4843238/London-listed-drugs-firm-Indivior-suffers-setback-U-S-patents-ruling.html",
    "date": "2017-09-01",
    "keywords": [
        "percent",
        "film",
        "suboxone",
        "market",
        "indivior",
        "treatment",
        "share",
        "year",
        "launch",
        "ruling",
        "reddys",
        "company",
        "guidance",
        "justin",
        "george",
        "court",
        "rival",
        "district",
        "judgment",
        "statement",
        "tablet",
        "drug",
        "timing",
        "analyst",
        "lawsuit",
        "risk",
        "drugmaker",
        "way",
        "addiction",
        "delaware",
        "firm",
        "drreddys",
        "alternative",
        "appeal",
        "total",
        "pence",
        "gmt",
        "tongue",
        "fall",
        "price",
        "reckitt",
        "benckiser",
        "impact",
        "loss",
        "consultation",
        "patient",
        "matter",
        "application",
        "anda",
        "june",
        "threat",
        "verdict",
        "commitment",
        "world",
        "dr",
        "approval",
        "case",
        "aggarwal",
        "credit",
        "half",
        "period",
        "form",
        "columbia",
        "strip",
        "version",
        "friday",
        "property",
        "revenue",
        "july",
        "range",
        "hence",
        "change",
        "visibility",
        "generic",
        "bengaluru",
        "editing",
        "edmund",
        "blair",
        "weir"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}